CYP2D6 phenotype prediction from genotype: which system is the best?

Clinical Pharmacology and Therapeutics
J Kirchheiner

Abstract

Genotyping of the polymorphic cytochrome P450 (CYP) 2D6 gene is used increasingly in clinical practice. Several psychiatric hospitals already use CYP2D6 testing before treating a patient with antidepressant or antipsychotic drug therapy. In other fields of drug therapy, such as for breast cancer, CYP2D6 status has been reported to be an independent predictor for the outcome with tamoxifen. Thus, a more favorable tamoxifen treatment seems to be feasible through a priori genetic assessment of CYP2D6.

References

Sep 17, 1977·Lancet·A MahgoubR L Smith
Sep 1, 1979·European Journal of Clinical Pharmacology·M EichelbaumH J Dengler
Jun 1, 1996·Pharmacogenetics·A K DalyU M Zanger
May 8, 1999·British Journal of Clinical Pharmacology·T FukudaJ Azuma
May 3, 2003·European Journal of Clinical Pharmacology·Myo-Kyoung KimIn-Jin Jang
Oct 8, 2004·Clinical Pharmacology and Therapeutics·Julia KirchheinerJürgen Brockmöller
Dec 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthew P GoetzJames N Ingle
Nov 23, 2006·Breast Cancer Research and Treatment·Matthew P GoetzJames N Ingle
Feb 3, 2007·European Journal of Clinical Pharmacology·D FrankU Fuhr
Nov 1, 2007·Clinical Pharmacology and Therapeutics·A GaedigkJ S Leeder

❮ Previous
Next ❯

Citations

Apr 10, 2009·European Journal of Clinical Pharmacology·Stacy S ShordRobert E Molokie
Dec 9, 2010·European Journal of Clinical Pharmacology·Trine Naalsund AndreassenOla Dale
Jul 7, 2011·Genetic Testing and Molecular Biomarkers·Laura N RiccardiSusi Pelotti
Apr 11, 2009·Child and Adolescent Psychiatry and Mental Health·Claudia Mehler-WexManfred Gerlach
Apr 5, 2011·Cleveland Clinic Journal of Medicine·Joseph P KitzmillerWolfgang Sadee
Apr 24, 2012·Expert Opinion on Pharmacotherapy·Hannu KokkiSari Sjövall
Jun 12, 2009·Drug Metabolism Reviews·Shu-Feng ZhouBalram Chowbay
Jan 19, 2016·Pharmacogenomics·Rashmi R ShahRobert L Smith
Jan 3, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Raja MehannaJoseph Jankovic
Jun 11, 2014·British Journal of Clinical Pharmacology·Rashmi R Shah, Robert L Smith
Feb 5, 2010·Journal of Thrombosis and Haemostasis : JTH·C S ZuernT Geisler
Sep 2, 2009·Acta Anaesthesiologica Scandinavica·S T ZwislerS H Sindrup
Apr 26, 2015·Clinical Pharmacokinetics·Dorte LassenKim Brøsen
May 13, 2009·Journal of Neural Transmission·Arun K TiwariDaniel J Müller
Mar 21, 2009·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Jaekyu ShinTaimour Y Langaee
Jan 23, 2009·The Clinical Journal of Pain·Anne N Nafziger, Joseph S Bertino
Nov 12, 2009·Clinical Pharmacokinetics·Shu-Feng Zhou
Dec 19, 2014·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Rashmi R Shah, Robert L Smith
Nov 12, 2019·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Andrea FanelliRita Maria Melotti
Jan 2, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Vincent O DezentjéHans Gelderblom
Jul 22, 2008·Therapeutic Drug Monitoring·Marianne Gex-FabryGilles Bertschy
Nov 26, 2009·Translational Research : the Journal of Laboratory and Clinical Medicine·Gerald W Dorn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here